Highly efficient deep-blue emitting CsPbBr(3) nanoplatelets synthesized via surface ligand-mediated strategy.

Zhang X, Cui Y, Ye S, Lin Z, Li Y

Molecular classification of geriatric breast cancer displays distinct senescent subgroups of prognostic significance.

Wu X, Chen M, Liu K, Wu Y, Feng Y, Fu S, Xu H, Zhao Y, Lin F, Lin L, Ye S, Lin J, Xiao T, Li W, Lou M, Lv H, Qiu Y, Yu R, Chen W, Li M, Feng X, Luo Z, Guo L, Ke H, Zhao L

A GPU-accelerated Monte Carlo code, RT(2)for coupled transport of photon, electron/positron, and neutron.

Lee CM, Ye SJ

Structure defining of ultrapotent neutralizing nanobodies against MERS-CoV with novel epitopes on receptor binding domain.

Ma S, Zhang D, Wang Q, Zhu L, Wu X, Ye S, Wang Y

FNIP1 suppresses colorectal cancer progression through inhibiting STAT3 phosphorylation and nuclear translocation.

Zhang G, Chen X, Yu C, Cui L, Chen N, Yi G, Wang S, Wei H, Liang Y, Ye S, Zhou Y

Highly potent and broadly neutralizing anti-CD4 trimeric nanobodies inhibit HIV-1 infection by inducing CD4 conformational alteration.

Zhu L, Huang B, Wang X, Ni F, Ao M, Wang R, Zheng B, Chen C, Xue J, Zhu L, Yang C, Shi L, Geng S, Hu J, Yang M, Zhang D, Yang P, Li M, Li Y, Hu Q, Ye S, Zheng P, Wei H, Wu Z, Zhang L, Wang Y, Liu Y, Wu X

Urinary alkylresorcinol metabolites, biomarkers of whole grain wheat and rye intake, are beneficially associated with liver fat and other fat measures.

Sun Z, Shao Y, Zhang X, Zhou Z, Ye S, Liu M, Lv Y, Xie S, Cao H, Zhang Z, Yang W

Development of an Injectable, ECM-Derivative Embolic for the Treatment of Cerebral Saccular Aneurysms.

Kim S, Nowicki KW, Kohyama K, Mittal A, Ye S, Wang K, Fujii T, Rajesh S, Cao C, Mantena R, Barbuto M, Jung Y, Gross BA, Friedlander RM, Wagner WR

PDP1 promotes KRAS mutant colorectal cancer progression by serving as a scaffold for BRAF and MEK1.

Yuan M, Zhang C, Chen S, Ye S, Liu H, Ke H, Huang J, Liang G, Yu R, Hu T, Wu X, Lan P

Efficacy and safety of chiauranib in a combination therapy in platinum-resistant or refractory ovarian cancer: a multicenter, open-label, phase Ib and II study.

Li J, Liu J, Yin R, Zou D, Zheng H, Cao J, Chen Z, Sun W, Gao Y, Zhang S, Zeng L, An R, Lu X, Ye S, Wu X